On occasion, we profile some biosimilar manufacturers about whom our readers may not be familiar. This generally refers to companies with products that are in earlier-stage research or those who simply have not been in the news as often as their colleagues. In this post, we highlight a European company, Polpharma Biologics. The drug maker … Continue reading A Profile of a Lesser-Known Player in the Biosimilar Space: Polpharma Biologics →